Labshake search
Citations for Tocris :
51 - 100 of 239 citations for Calcium Channel Voltage Dependent L Type Alpha 1C Subunit CACNA1C Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... cells were voltage clamped at Erev GABAA (−70 mV) in the presence of 1 uM Tetrodotoxin (Tocris). For mIPSC recordings ...
-
bioRxiv - Animal Behavior and Cognition 2022Quote: ... whole-cell recordings in the voltage clamp configuration (Vhold = - 65mV) were performed in 1μM TTX and 2.5mM MNI-glutamate (Tocris) containing ACSF at 30°C ...
-
bioRxiv - Neuroscience 2021Quote: ... For L-3,4-Dihydroxyphenylalanine (L-DOPA, Tocris Bioscience) treatment ...
-
bioRxiv - Biophysics 2019Quote: ... and paralyzed by injecting 1-2 nL of 500 µM alpha-bungarotoxin (TOCRIS) in the caudal muscles of the trunk ...
-
bioRxiv - Neuroscience 2020Quote: ... a cesium sulfate-based internal solution containing the sodium channel blocker QX314 (2mM, Tocris Bioscience) was used to stabilize recordings during prolonged depolarization ...
-
bioRxiv - Neuroscience 2023Quote: ... we applied for 5 minutes the specific sodium channel blocker tetrodotoxin (TTX, 500 nM, Tocris) in combination with potassium channel blocker 4-aminopyridine (4-AP ...
-
bioRxiv - Neuroscience 2021Quote: ... Whole-cell voltage-clamp recordings for mEPSC and mIPSC were conducted in the presence of TTX (1 μM; Tocris) and Picrotoxin (100 uM ...
-
bioRxiv - Neuroscience 2021Quote: ... Drug application for pharmacological manipulation of voltage response was performed by bath application (100 nM α-dendrotoxin, Tocris-Cookson).
-
bioRxiv - Neuroscience 2024Quote: ... mEPSC recordings were obtained from cells voltage-clamped at –70 mV in ACSF containing 0.5 µM tetrodotoxin (TTX, Tocris) and 50 µM picrotoxin (PTX ...
-
bioRxiv - Neuroscience 2023Quote: ... sIPSC recordings were performed in voltage clamp mode in the presence of 20 μM AMPA/Kainate receptor antagonist CNQX (Tocris) and 50 μM NMDA receptor antagonist AP5 (Tocris) ...
-
bioRxiv - Neuroscience 2024Quote: ... Recordings of spontaneous and miniature excitatory postsynaptic currents (sEPSC, mEPSCs) were performed in voltage-clamp at –70 mV in the presence of gabazine (1μM; Tocris Bioscience) and CGP55845 (2μM ...
-
bioRxiv - Neuroscience 2023Quote: L-DOPA (3788) and L-741,626 (1003) were from Tocris. Methylphenidate and desipramine were from Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... and Ih - producing hyperpolarization-activated cyclic nucleotide (HCN) channels with ZD 7288 (30–50 µM; Tocris). IPump was potentiated by monensin (monensin sodium salt ...
-
bioRxiv - Neuroscience 2020Quote: ... L-689,560 (Tocris); a catalytic subunit of protein kinase A (PKA Cα ...
-
bioRxiv - Neuroscience 2020Quote: ... and 10 L-741626 and L-745870 (both from Tocris Bioscience) to block D2 and D4 receptors respectively ...
-
bioRxiv - Neuroscience 2021Quote: ... cells were whole-cell voltage-clamped at −40mV and recorded in the presence of the GABAAR antagonist Gabazine (10 μM, Tocris 1262). N-methyl-D-aspartic acid (NMDA ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience), were freshly diluted and bath-applied through the perfusion line 10 minutes before recording ...
-
bioRxiv - Neuroscience 2020Quote: ... MNI-caged L-glutamate (4-methoxy-7-nitroindolinyl-caged L-glutamate, Tocris) was uncaged with a train of 8–10 ms laser pulses (under the objective ...
-
bioRxiv - Neuroscience 2019Quote: ... were measured in voltage clamp at a holding potential of −60 mV in the presence of 1 μM tetrodotoxin (Tocris, Bristol, UK) and 100 μM picrotoxin (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... L-AP4 (TOCRIS, #0103), Latrunculin B (Bio-Connect ...
-
bioRxiv - Neuroscience 2022Quote: ... 20μM L-AP4 (Tocris), 100μM picrotoxin (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2023Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 µM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Pathology 2023Quote: ... CoCl2 (200 μmol/L) and DPD (20 μmol/L) or the HIF-1 inhibitor chetomin (Tocris, Bristol, United Kingdom, 12 nmol/L).
-
bioRxiv - Neuroscience 2021Quote: ... d-2-Amino-5-phosphonovaleric acid (d-AP5, 50µM) and the sodium (Na+) channel blocker tetrodotoxin (TTX, 1 µM Tocris). Individual traces (5 sec duration ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA channel blocker Picrotoxin (50 µM) or the GABAB antagonist CGP-54626 (3 µM) (Tocris Bioscience, Minneapolis, MN) was bath applied 80 min prior to HFS ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the bath through the perfusion system for 10 minutes before recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 μM, Tocris Bioscience, Bristol, UK) were diluted to the appropriate concentration from stock solutions and added to the Ames medium before recordings.
-
bioRxiv - Neuroscience 2024Quote: ... L-(+)-2-amino-4-phosphonobutyric acid (L-AP4, 50 mM, Tocris Bioscience, Bristol, UK) was added.
-
bioRxiv - Neuroscience 2022Quote: ... L-741,626 (Tocris Bioscience, 1003), Pyr-3 (Tocris,3753) ...
-
bioRxiv - Neuroscience 2022Quote: ... L-AP4 (20 µM, Tocris), ACET (10 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... OTA (L-368,899) (Tocris, #2641) was dissolved in ddH2O at 10 mg/ml and was further diluted to 2 mg/ml in saline for intra-CeL injections (1 μg in 0.5 μl) ...
-
bioRxiv - Neuroscience 2021Quote: ... 0.005 mM L-AP4 (Tocris) for activating type 6 metabotropic glutamatergic receptors (mGluR6 ...
-
bioRxiv - Neuroscience 2020Quote: MNI-caged-L-glutamate (Tocris) releases glutamate with exposure to 300-380 nm light ...
-
bioRxiv - Neuroscience 2021Quote: L-Glutamic acid (Tocris, UK) was dissolved in ACSF to a concentration of 200 mM and the pH adjusted to 7.4 with NaOH ...
-
bioRxiv - Neuroscience 2023Quote: ... 40µm L-AP4 (Tocris #0103), 100µm CNQX (Tocris #0190 ...
-
bioRxiv - Neuroscience 2024Quote: ... L-glutamic acid (Tocris, UK) was dissolved in 50 mM NaOH ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Immunology 2019Quote: ... neutrophils were stimulated with fMLP (1 μM) in presence of various inhibitors: calcium chelator (BAPTA-AM, 10 μM, Tocris), inhibitor of calcium-activated chloride channel (CaCCinh-A01 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1.5 μL of L-NIO (N5-(1-Iminoethyl)-L-ornithine) (Cat. No. 0546, Tocris solution) (27.4 mg/ml (130 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... 1.5 μL of L-NIO (N5-(1-Iminoethyl)-L-ornithine) (Cat. No. 0546, Tocris solution) (27.4 mg/ml in sterile PBS ...
-
bioRxiv - Biophysics 2019Quote: ... Samples of antagonist-bound TRPA1 were acquired by incubating the purified channel with 10 µM A-967079 (A-96) (Tocris) for 10 mins ...
-
bioRxiv - Neuroscience 2020Quote: ... the synaptic NMDARs thus activated were blocked by application of the open-channel irreversible antagonist MK-801 (10 µM, Tocris) in the continued presence of bicuculline for 5 min ...
-
bioRxiv - Physiology 2023Quote: ... GSK1016790A (GSK101, TRPV4 agonist), AR-C 118925XX (ARC, P2Y2R inhibitor) and Ruthenium Red (TRPV4 channel blocker) were purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Biophysics 2023Quote: ... The Piezo1 channel activator Yoda1 (5, 10, 20 or 30 μM, dissolved in 10 mM DMSOt, Tocris Bioscience, Bristol, UK) and the Transient Receptor Potential Vanilloid (TRPV4 ...
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...